Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07833891 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Senocohort: Identification of Predictive Biomarkers in Breast Cancer Treatment

Name: Senocohort: Identification of Predictive Biomarkers in Breast Cancer Treatment — clinical trial record (NCT07833891)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SENOCOHORT

StatusNot Yet Recruiting

PhaseNot specified

SponsorAssistance Publique - Hôpitaux de Paris

Started2026-10-01

View on ClinicalTrials.gov ↗

Assistance Publique - Hôpitaux de Paris

1,338 trials monitored

See 38 trials at risk

Breast Cancer

5,180 trials monitored

See 256 trials at risk

Triple-Negative Breast Cancer

594 trials monitored

See 37 trials at risk

Breast cancer is a heterogeneous disease with multiple molecular subtypes, each requiring tailored therapeutic strategies. The recent introduction of targeted therapies, immunotherapies, and antibody-drug conjugates has expanded treatment options, yet their efficacy varies depending on tumor subtype. This non-interventional study aims to identify novel predictive biomarkers of response or resistance to these emerging therapies. The Senocohort study will prospectively collect clinical, biological, imaging, and organoid-derived data from breast cancer patients, with a focus on hormone receptor-negative tumors. The ultimate goal is to improve precision medicine strategies and patient stratification

Trial Details

NCT Number	NCT07833891
Lead Sponsor	Assistance Publique - Hôpitaux de Paris
Conditions	Breast Cancer, Breast Cancer (Triple Negative Type)
Enrollment	500 participants
Start Date	2026-10-01
Primary Completion	2031-10-01 (estimated)
Study Completion	2041-10-01 (estimated)
Updated on ClinicalTrials.gov	2026-09-22